NIAGEN BIOSCIENCE, INC.: accounts_receivable
| Value | {"amount": 2694000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | NIAGEN BIOSCIENCE, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:23:03.592040+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1b07d3d4-a765-43f4-88e0-c43738b7955f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-21-015375Retrieved: 2026-08-19T13:23:03.592040+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001386570/accounts-receivable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1b07d3d4-a765-43f4-88e0-c43738b7955f
History
- no predecessors — first report